Balance Sheet Components (Tables)

6 Months Ended

Jun. 30, 2024

Disclosure Of Balance Sheet Components [Abstract]

Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same amounts shown in the condensed consolidated statements of cash flows (in thousands):


		June 30, 2024				December 31, 2023
Cash		$	2,939			$	8,488
Cash equivalents			154,365				216,622
Cash and cash equivalents			157,304				225,110
Restricted cash			1,032				1,032
Cash, cash equivalents and restricted cash		$	158,336			$	226,142

Summary of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


		June 30, 2024				December 31, 2023
Prepaid research and development costs		$	4,130			$	2,617
Prepaid insurance			309				704
Other prepaid expenses			831				760
Other current assets			—				63
Total prepaid expenses and other current assets		$	5,270			$	4,144

Summary of Property and Equipment, Net

Property and equipment, net, consisted of the following (in thousands):


		June 30, 2024				December 31, 2023
Leasehold improvements		$	17,245			$	17,245
Laboratory equipment			1,832				1,832
Furniture and fixtures			692				692
Computer equipment and software			33				33
Construction in progress			4				—
Total property and equipment, gross			19,806				19,802
Less: accumulated depreciation			(6,104	)			(5,029	)
Total property and equipment, net		$	13,702			$	14,773

Summary of Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):


		June 30, 2024				December 31, 2023
Accrued research and development expenses		$	6,538			$	4,027
Accrued compensation			2,766				5,607
Accrued professional services			1,240				501
Other accrued expenses			113				100
Total accrued liabilities		$	10,657			$	10,235